Skip to Content
Merck
  • Alternating hemiplegia of childhood: successful treatment with topiramate and flunarizine, a case report.

Alternating hemiplegia of childhood: successful treatment with topiramate and flunarizine, a case report.

Annals of tropical paediatrics (2011-05-18)
R Aishworiya, P S Low, S K H Tay
ABSTRACT

Alternating hemiplegia of childhood (AHC) is a rare neurological disorder which usually presents before 18 months of age and is characterised by recurrent alternating episodes of hemiparesis. A single effective treatment for this condition is yet to be established; flunarizine is currently the most widely used but with varying degrees of success. An 18-month-old child presented with AHC and treatment with a combination of topiramate and flunarizine made a significant difference in controlling the frequency and severity of the attacks. This possibly allowed a better developmental outcome than in most children with this condition. Topiramate combined with flunarizine for treating AHC has much potential for further research.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Flunarizine dihydrochloride, ≥98% (TLC)